H igh-risk atherosclerotic plaques are pathologically characterized by a thin fibrous cap and substantial plaque burden with a large necrotic core, intense macrophage infiltration, and spotty calcification (1) (2) (3) (4) (5) . Multiple invasive imaging modalities can reliably identify these markers but their ability to predict long-term outcomes has been rather modest (2, 6) . Noninvasive imaging modalities, such as computed tomography (CT), have been used to identify many of these high-risk plaque features (7) and reveal that coronary artery calcification (CAC) is one of the strongest predictors of future cardiac events (8) . However, few studies have related CAC on CT to coronary plaque volume. Importantly, progression of CAC and overall plaque volume has potent adverse consequences (9) 
CAC AND STATINS AND EVENTS
Multiple observations suggest that statin therapy, which markedly reduces overall cardiovascular events, seems to increase atherosclerotic plaque density and CAC scores on CT (1 reported that they have no relationships relevant to the contents of this paper to disclose. 
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